K2 HealthVentures Equity Trust LLC

13D and 13G Filings

13D/G filings
13G on 3 securities
CIK
0001948604
All SEC filings
View on sec.gov
Issuer % of Class Filed
Neumora Therapeutics, Inc. 13G/A Amendment 2
NMRA · 640979100
3.1% 5/15/2026
Event 3/31/2026
Neumora Therapeutics, Inc. 13G/A Amendment 1
NMRA · 640979100
5.0% 2/17/2026
Event 12/31/2025
Alto Neuroscience, Inc. 13G/A Amendment 1
ANRO · 02157Q109
2.4% 2/17/2026
Event 12/31/2025
Neumora Therapeutics, Inc. 13G
NMRA · 640979100
6.6% 8/11/2025
Event 5/9/2025
Alto Neuroscience, Inc. 13G
ANRO · 02157Q109
5.6% 5/15/2025
Event 1/13/2025
TScan Therapeutics, Inc. 13G/A Amendment 3
TCRX · 89854M101
6.9% 2/14/2025
Event 12/31/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.